BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
GATA1
,
Metabolism of xenobiotics
,
HIV infection
,
Lung
,
Avian flu virus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
leukemia biphenotypic, acute
Summary
General Info
Curated Studies
Most Correlated Studies
Acute myeloid leukemia cells treated with cell-specific IC50 concentrations of etoposide
Acute leukemia cells treated with cell-permeable chemical degrader of TRIM24
Leukemia K-562, MOLM13 and MV-4-11 cells treated with imatinib or AC220 compound
Mixed lineage leukemia cell lines treated with a DOT1L inhibitor
Leukemia MOLM-13 cells with CRISP-Cas9 mediated CLPB knockout
Explore Curated Studies Results
Literature
Most Relevant Literature
Diagnosis of biphenotypic acute leukemia: a paradigmatic approach.
Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that…
Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acu…
Outcomes of CAG regimen for refractory biphenotypic acute leukemia patients.
Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-R…
Acute Lymphoblastic Leukemia Registry at Asan Medical Center
Management of Mixed-Phenotype Acute Leukemia in the East of France
Alisertib for Acute Myeloid Leukemia
Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cel…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ